Introduction
Precise postoperative monitoring and management are essential in paediatric cardiothoracic surgery,Reference Spenceley, MacLaren, Kissoon and Macrae1 particularly for patients with single ventricle physiology, where postoperative morbidity and mortality rates remain elevated.Reference Oster, Knight, Suthar, Amin and Kochilas2 Transthoracic intracardiac lines have evolved to be common practice in postoperative care given their capacity to monitor intra-cardiac pressures, ventricular compliance, and for medication and nutrition administration.Reference Krishnamoorthy, Gadhinglajkar, Palanisamy, Sreedhar, Babu and Dharan3–Reference Beham, Dave, Kelly, Frey, Hug and Brotschi6 These lines can also be advantageous for single ventricle patients, as they help preserve vascular access for future surgical palliationsReference Kaipa, Mastropietro, Bhai, Lutfi, Friedman and Yabrodi7 and provide an alternative in patients for whom peripherally inserted central catheter access is not feasible.Reference Beham, Dave, Kelly, Frey, Hug and Brotschi6 Emerging literature suggests that the complication rates associated with transthoracic intracardiac lines are comparable to peripherally inserted central cathetersReference Krishnamoorthy, Gadhinglajkar, Palanisamy, Sreedhar, Babu and Dharan3,Reference Flori, Johnson, Hanley and Fineman4,Reference Beham, Dave, Kelly, Frey, Hug and Brotschi6,Reference Gold, Jonas, Lang, Elixson, Mayer and Castaneda8,Reference Anton-Martin, Zook, Kochanski, Ray, Nigro and Vellore9 ; however, the use and complications of transthoracic intracardiac lines in single ventricle patients remain understudied. This study aimed to more comprehensively characterise factors associated with transthoracic intracardiac line complications within the single ventricle population.
Materials and methods
Study cohort
We performed a retrospective cohort review of postoperative single ventricle patients undergoing cardiothoracic surgeries between January 1, 2011 and June 30, 2018 at a tertiary level paediatric cardiovascular ICU. Patients who had incomplete data were greater than 18 years of age or deemed to have biventricular physiology were excluded. Single ventricle physiology was determined by the specific anatomical lesion and/or by multidisciplinary discussion within the heart centre. This is a secondary analysis of the study by Anton-Martin et alReference Anton-Martin, Zook, Kochanski, Ray, Nigro and Vellore9 focusing exclusively on the single ventricle patient cohort and specifically refers to intra-atrial lines.
Patient demographics, cardiac anatomy, surgical data, haematological profile, line characteristics, line duration, and complications were collected from the medical records. Patient demographics included age at surgery, prematurity (< 37 weeks gestation), weight, gender, race, whether the patient’s congenital heart disease was diagnosed prenatally, clinical syndrome/association, diagnosed genetic abnormality and presence of non-cardiac anomalies. Surgeries were classified as either staged palliation operations (Blalock-Taussig-Thomas shunt, central shunt, cavo-pulmonary connections, hybrid procedures or pulmonary artery banding) or non-palliation. Operational data included cardiopulmonary bypass time, cross clamp time, deep hypothermic circulatory arrest time, and preoperative or postoperative extracorporeal membrane oxygenation use.
Transthoracic intracardiac line details included number of lumens, duration of use, and time from line removal to discharge. Complications included line infection, malfunction, migration, and thrombosis, which were confirmed by chart review of medical documentation, echocardiograms, and blood cultures. Infection was defined as clinical signs of infection with positive blood culture obtained from the line. Malfunction was defined as catheter leakage or rupture, inability to infuse or aspirate from the line unrelated to a thrombus and/or no dampened or no waveform tracing. Migration was defined as accidental extrusion of the line outside of the atrium. Thrombosis was defined as inability to aspirate or infuse through the line requiring thrombolysis and/or a line-related thrombus in the atrium on echocardiogram. Intra-atrial pressure and a patient’s haematological profile (haemoglobin, platelet count, prothrombin time, international normalised ratio, partial thromboplastin time, and fibrinogen) at time of line removal were also obtained. Outcomes were length of hospital stay, duration of mechanical ventilation, failed extubation, surgery to discharge time, and survival to hospital discharge.
Line placement, management, and removal
All lines were placed at the end of the operation by the cardiothoracic surgeon. Placement technique is patient specific. For specific surgical technique, refer to the main paper by Anton-Martin et al.Reference Anton-Martin, Zook, Kochanski, Ray, Nigro and Vellore9 At this institution, typically all continuous medications were moved to the transthoracic intracardiac line within the first postoperative day if the patient was haemodynamically stable; the line was then used as the primary point of central access. Line position was confirmed by chest X-ray postoperatively and echocardiogram. Other central access lines were removed within 72 hours postoperatively unless additional access was needed.
Statistical analysis
Data were presented as medians and interquartile ranges (1st, 3rd) for continuous variables and as a count (percentage) for categorical variables. Bivariate analyses were conducted using Chi-squared tests and Wilcoxon–Mann–Whitney tests to ascertain the association between covariates and line complications. Backward selection was employed to identify potential predictors of complications. A priori, the variables considered included age, weight, prematurity, presence of a syndrome, chromosomal abnormalities, noncardiac anomalies, type of surgery (palliation vs. shunt), and line duration, based on their clinical relevance and the limited sample size (due to the small number of complications). Only pre-specified variables that demonstrated statistical significance in the bivariate analysis were incorporated into the model selection process. Odd ratios and 95% confidence intervals were provided for the final model. P-values were 2 sided and a P-value ≤ 0.05 was considered statistically significant. Analyses were performed using SAS (version 9.4, SAS Institute Inc., North Carolina, United States of America).
Results
Patient population
During the study period, 692 patients underwent cardiothoracic surgeries and 245 of them (35.4%) had single ventricle physiology. Of the single ventricle patients, there were a total of 338 transthoracic intracardiac lines placed through various admissions and surgeries. Median age and weight were 74.5 days (8, 207) and 3.6 kg (3.1, 6.2). Of those, 143 (58.4%) were neonates and 26 (10.6%) were premature. One hundred forty-seven (60%) patients were male and majority were Caucasian (52.7%). Roughly one-third of patients had concern for a genetic syndrome. Most surgeries were palliation (84%) and 35.5% of surgeries included a shunt of some type; 72% of surgeries were completed on bypass. Median time from surgery to discharge was 16 (11, 30) days. Overall mortality was 5.7% (Table 1).
Table 1. Characteristics of single ventricle patients, transthoracic intracardiac lines, complications, and outcomes

a Median, interquartile range (1st IQR, 3rd IQR).
b Frequency (%).
CPB = cardiopulmonary bypass, DHCA = deep hypothermic circulatory arrest; g/dL = grams per decilitre; INR = international normalised ratio; IQR = interquartile ranges; ECMO = extracorporeal membrane oxygenation; mg/dL = milligrams per decilitre; mmHg = millimetres of mercury; MV = mechanical ventilation; PT = prothrombin time; PTT = partial thromboplastin time.
The majority of transthoracic intracardiac lines were double lumen (88.9%). Lines remained in place a median of 14 (8, 23) days and generally were removed the day of discharge. There was no significant coagulopathy or thrombocytopenia at the time of removal and intra-atrial pressures averaged at 7 mmHg (4, 10). A total of 21 (6.2%) line complications occurred. The most frequent complication was migration (n = 8, 2.4%) followed by thrombosis (n = 7, 2.1%). Four (1.2%) lines malfunctioned, and 2 (0.6%) lines became infected. There was no mortality associated with transthoracic intracardiac line complications. However, line migration necessitated emergent interventions, including pericardial drainage (n = 1), chest tube placement (n = 1), and blood transfusion (n = 1). Characteristics are summarised in Table 1.
Table 2 summarises patient and surgical characteristics, outcomes, and management of transthoracic intracardiac lines on their associations with line complications. Complications occurred more frequently in patients with shunts (57.1% vs 34.1%; P 0.03) and in those who needed postoperative extracorporeal membrane oxygenation (14.3% vs 3.5%; P 0.03). Line duration was longer in patients with complications compared to those without [20 (7, 44) vs 13 (7, 21) days; P < 0.001]. In patients without complications, line removal was performed closer to the time of hospital discharge [0 (0, 3) vs 8 (0, 34) days; P < 0.0001]. Patients who had complications generally had a longer length of stay [52 (23, 71) vs 22 (12, 40) days; P < 0.0001] and longer mechanical ventilation time [8 (3, 28) vs 3 (1, 12); P < 0.01]. Among the variables evaluated for inclusion in model development, shunt placement and line duration met criteria for further consideration. Following model selection, only shunt placement was found to be a significant predictor of line complications (odds ratio 2.58, confidence interval 1.05 – 6.31; P 0.03).
Table 2. Demographic and clinical characteristics of all transthoracic intracardiac lines with and without complications

a Median, interquartile range (1st IQR, 3rd IQR).
b Frequency (%).
CPB = cardiopulmonary bypass, DHCA: deep hypothermic circulatory arrest; ECMO = extracorporeal membrane oxygenation, g/dL = grams per decilitre; INR = international normalised ratio; mg/dL = milligrams per decilitre; mmHg = millimetres of mercury; MV = mechanical ventilation; PTT = partial thromboplastin time.
Discussion
This is the first study to characterise the use of transthoracic intracardiac lines and to evaluate factors associated with complications specifically in patients with single ventricle physiology; a population that necessitates meticulous lifelong care. The cohort’s overall complication rate was 6.2% which is similar when compared to other transthoracic intracardiac line studies (0.6–19%)Reference Krishnamoorthy, Gadhinglajkar, Palanisamy, Sreedhar, Babu and Dharan3,Reference Flori, Johnson, Hanley and Fineman4,Reference Beham, Dave, Kelly, Frey, Hug and Brotschi6,Reference Gold, Jonas, Lang, Elixson, Mayer and Castaneda8–Reference Garcia, Pye, Tang, Gossett, Prodhan and Bhutta13 and other central venous access (2.2−31.3%).Reference Gonzalez and Cassaro14 –Reference de Jonge, Polderman and Gemke18 The most common complication was migration of the line which was 2.4% and similar to other transthoracic line studies (1.2-5.3%).Reference Flori, Johnson, Hanley and Fineman4,Reference Gold, Jonas, Lang, Elixson, Mayer and Castaneda8,Reference Kumar, Subramanian and Tansey10,Reference Pratap, Millar, Butt and d’Udekem11
Surgery involving a shunt placement was associated with higher rates of line complications. Single ventricle patients with shunts typically have tenuous cardiopulmonary haemodynamics resulting in elevated rates of morbidity and mortality.Reference Oster, Knight, Suthar, Amin and Kochilas2,Reference Alsoufi, McCracken, Oster, Shashidharan and Kanter19–Reference Sower, Romano, Yu, Lowery, Pasquali and Zampi23 This may have influenced the observed findings. Furthermore, their severity of illness and associated high incidence of complications, such as necrotising enterocolitis,Reference Giannone, Luce, Nankervis, Hoffman and Wold24,Reference Kelleher, McMahon and James25 often necessitate long-term vascular access, which may further influence the overall complication rates.
Sustaining peripheral access in any cardiac patient can be challenging, and certain protocols have been formed to help preserve vascular sites.Reference Aiyagari, Cooper and Jacobs26 The single ventricle population in particular is medically fragile, often necessitating frequent admissions with the need for long-term vascular access.Reference Tabtabai, DeFaria Yeh, Stefanescu, Kennedy, Yeh and Bhatt27 Additionally, any procedure involving peripheral access or administration of anaesthetics poses a risk of cardiopulmonary collapse in this population.Reference Brown, DiNardo and Odegard20,Reference Christensen, Gholami, Reynolds and Malviya28–Reference Leyvi and Wasnick30 Thoughtful evaluation of placement and maintenance of vascular access is thus essential to help preserve these sites for future use.Reference Aiyagari, Cooper and Jacobs26 Utilising transthoracic lines as the primary access point following cardiac surgery in these patients may contribute significantly to achieving this endeavour.
Generally, there is a preference for patients with single ventricle physiology to sustain lower extremity peripherally inserted central catheters to preserve the upper chest vasculature from thrombosis.Reference Kaipa, Mastropietro, Bhai, Lutfi, Friedman and Yabrodi7 This preservation is imperative and life sustaining for future interventions, including superior cavo-pulmonary connections, cardiac catheterizations, and the potential need for heart transplantation.Reference Kaipa, Mastropietro, Bhai, Lutfi, Friedman and Yabrodi7 Furthermore, single ventricle patients are at increased risk of lymphatic complications due to factors such as inadvertent thoracic duct injury or obstruction, change in venous flow from palliative surgeries, and increased lymphatic production from elevated venous pressures.Reference Dori and Smith31–Reference Chang, Huang and Chen33 While recent literature suggests that upper extremity peripherally inserted central catheters in patients with single ventricle physiology are associated with low rates of catheter-associated thrombosis and venous stenosis,Reference Kaipa, Mastropietro, Bhai, Lutfi, Friedman and Yabrodi7 they may exacerbate the potential risk of increased lymphatic pressure and chylothorax.Reference Hsu, Chou, Wang and Wu34–Reference Dhande, Kattwinkel and Alford36 The utilisation of transthoracic intracardiac lines can mitigate these risks while preserving vascular access in both the upper and lower extremities.
Our study is subject to several limitations. This cohort was derived from a single-centre and employed a retrospective design. Additionally, we were unable to adjust for severity of illness, which is likely an important confounder in our findings. Institutional practices and experience must also be considered when interpreting the applicability of these results. The specific surgical techniques for transthoracic intracardiac line placement may vary, with certain methods potentially increasing the risk of line complications such as migration and malfunction.Reference Kumar, Subramanian and Tansey10 In our cohort, the technique employed a securing cuff positioned beneath the skin, which may have helped mitigate these complications.Reference Anton-Martin, Zook, Kochanski, Ray, Nigro and Vellore9 Additionally, it is essential to recognise the learning curve associated with these procedures; therefore, establishment of protocols and techniques for placement, maintenance, and removal of these lines, as well as ongoing education for nursing staff, advanced practice providers, physical and occupational therapists, and physicians is crucial to ensure safe management of these lines and to minimise risk to patients.
Transthoracic intracardiac lines, particularly intra-atrial lines, represent safe alternatives to other central catheters and should be strongly considered as a primary option for long-term access in patients with single ventricle physiology in the postoperative period. Implementing multidisciplinary heart centre protocols for surgical techniques, management, and removal of these lines can contribute to reduced complication rates and, consequently, improved outcomes in this high-risk population.
Acknowledgements
None.
Financial support
The statistical work was supported by the St Jude Pediatric Research Recruitment Support Fund hosted by P.A.M. (R079700556).
Competing interests
The authors declare no conflicts of interest with respect to the authorship and/or publication of this manuscript.
Ethical standards
The authors assert that all procedures contributing to this work comply with the ethical standards of the Helsinki Declaration of 1975, as revised in 2008, and has been approved by The Institutional Review Board of Phoenix Children’s Hospital.